MedTrace Logo

Assessment of Disease Burden and Palliative Care Needs of Patients During the Course of Incurable Cancer Disease

NCT02751723 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-03-07

No results posted yet for this study

Summary

The aim of this non-investigational study is to determine the symptoms and disease burden at the time point of diagnosis and in the further course of an incurable cancer disease. The needs and preferences of patients suffering from cancer (ovarian carcinoma, breast cancer, malignant melanoma, lung cancer, stomach cancer, oesophageal cancer, pancreatic cancer, cancer of the hepatobiliary system, colorectal cancer, head and neck cancer) are examined by various validated questionnaires. The data obtained by these questionnaires are collected together with information obtained by the treating physicians at four time points during the study: t0 - patient´s enrollment, at the moment of diagnosis and before the start of tumor therapy, respectively; T1 - 3 months after patient´s enrollment; T2 - 6 months after patient´s enrollment; T3 - 12 months after patient´s enrollment. This highly innovative project offers the chance to identify medical services deficits and risk circumstances for the burden of treatments in an oncology-palliative setting and to optimize the quality of patient care.

Conditions

  • Cancer Disease, Palliative Therapy

Interventions

OTHER

validated questionnaires

Sponsors & Collaborators

  • Florian Lordick, MD

    lead OTHER

Principal Investigators

  • Florian Lordick, Prof. Dr. · University of Leipzig

  • Bend Alt-Epping, PD Dr. · University of Göttingen

  • Anja Mehnert, Prof. Dr. · University of Leipzig

  • Birgitt van Oorschot, Prof. Dr. · Comprehensive Cancer Centre Main-Franken, Würzburg

  • Michael Thomas, Prof. Dr. · Heidelberg University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2019-10-31
Completion
2019-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02751723 on ClinicalTrials.gov